Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) predominantly affect women who are of childbearing age. Understanding the interactions between pregnancy and NMOSD is important for clinical management. Aquaporin-4 (AQP4), the most common target antigen in NMOSD, is expressed on placenta in early pregnancy. A variety of immune and cytokine changes in pregnancy may impact pregnancy outcomes in NMOSD patients. Relapses continue during pregnancy and increase in frequency postpartum. Preeclampsia and fetal loss are more frequent in NMOSD than in controls. Transfer of AQP4-immunoglobulin G (IgG) from mother to baby occurs but appears not to cause disease. Several treatment options are relatively safe and mitigate the risk of relapse during pregnancy and postpartum. For patients with active NMOSD, it may be advisable to continue immunotherapy during pregnancy.

Original languageEnglish (US)
Pages (from-to)1808-1817
Number of pages10
JournalMultiple Sclerosis
Volume23
Issue number14
DOIs
StatePublished - Dec 1 2017

Fingerprint

Neuromyelitis Optica
Pregnancy
Aquaporin 4
Postpartum Period
Recurrence
Pregnancy Outcome
Pre-Eclampsia
Immunotherapy
Placenta
Immunoglobulin G
Mothers
Cytokines
Antigens

Keywords

  • breast feeding
  • immunosuppressive safety
  • miscarriage
  • NMOSD
  • pregnancy
  • relapse rate

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Neuromyelitis optica spectrum disorders and pregnancy : Interactions and management. / Shosha, Eslam; Pittock, Sean J; Flanagan, Eoin; Weinshenker, Brian G.

In: Multiple Sclerosis, Vol. 23, No. 14, 01.12.2017, p. 1808-1817.

Research output: Contribution to journalReview article

@article{fa14c7f0f5034aa4bb35b1effaf1c9c4,
title = "Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management",
abstract = "Neuromyelitis optica spectrum disorders (NMOSD) predominantly affect women who are of childbearing age. Understanding the interactions between pregnancy and NMOSD is important for clinical management. Aquaporin-4 (AQP4), the most common target antigen in NMOSD, is expressed on placenta in early pregnancy. A variety of immune and cytokine changes in pregnancy may impact pregnancy outcomes in NMOSD patients. Relapses continue during pregnancy and increase in frequency postpartum. Preeclampsia and fetal loss are more frequent in NMOSD than in controls. Transfer of AQP4-immunoglobulin G (IgG) from mother to baby occurs but appears not to cause disease. Several treatment options are relatively safe and mitigate the risk of relapse during pregnancy and postpartum. For patients with active NMOSD, it may be advisable to continue immunotherapy during pregnancy.",
keywords = "breast feeding, immunosuppressive safety, miscarriage, NMOSD, pregnancy, relapse rate",
author = "Eslam Shosha and Pittock, {Sean J} and Eoin Flanagan and Weinshenker, {Brian G}",
year = "2017",
month = "12",
day = "1",
doi = "10.1177/1352458517740215",
language = "English (US)",
volume = "23",
pages = "1808--1817",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "14",

}

TY - JOUR

T1 - Neuromyelitis optica spectrum disorders and pregnancy

T2 - Interactions and management

AU - Shosha, Eslam

AU - Pittock, Sean J

AU - Flanagan, Eoin

AU - Weinshenker, Brian G

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Neuromyelitis optica spectrum disorders (NMOSD) predominantly affect women who are of childbearing age. Understanding the interactions between pregnancy and NMOSD is important for clinical management. Aquaporin-4 (AQP4), the most common target antigen in NMOSD, is expressed on placenta in early pregnancy. A variety of immune and cytokine changes in pregnancy may impact pregnancy outcomes in NMOSD patients. Relapses continue during pregnancy and increase in frequency postpartum. Preeclampsia and fetal loss are more frequent in NMOSD than in controls. Transfer of AQP4-immunoglobulin G (IgG) from mother to baby occurs but appears not to cause disease. Several treatment options are relatively safe and mitigate the risk of relapse during pregnancy and postpartum. For patients with active NMOSD, it may be advisable to continue immunotherapy during pregnancy.

AB - Neuromyelitis optica spectrum disorders (NMOSD) predominantly affect women who are of childbearing age. Understanding the interactions between pregnancy and NMOSD is important for clinical management. Aquaporin-4 (AQP4), the most common target antigen in NMOSD, is expressed on placenta in early pregnancy. A variety of immune and cytokine changes in pregnancy may impact pregnancy outcomes in NMOSD patients. Relapses continue during pregnancy and increase in frequency postpartum. Preeclampsia and fetal loss are more frequent in NMOSD than in controls. Transfer of AQP4-immunoglobulin G (IgG) from mother to baby occurs but appears not to cause disease. Several treatment options are relatively safe and mitigate the risk of relapse during pregnancy and postpartum. For patients with active NMOSD, it may be advisable to continue immunotherapy during pregnancy.

KW - breast feeding

KW - immunosuppressive safety

KW - miscarriage

KW - NMOSD

KW - pregnancy

KW - relapse rate

UR - http://www.scopus.com/inward/record.url?scp=85035023555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035023555&partnerID=8YFLogxK

U2 - 10.1177/1352458517740215

DO - 10.1177/1352458517740215

M3 - Review article

AN - SCOPUS:85035023555

VL - 23

SP - 1808

EP - 1817

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 14

ER -